Relmada Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RLMD and other ETFs, options, and stocks.About RLMD
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor antagonist for the treatment of CNS diseases, and oral agent for depression and other potential indications.
RLMD Key Statistics
Stock Snapshot
The current Relmada Therapeutics(RLMD) stock price is $4.18, with a market capitalization of 317.55M. The stock trades at a price-to-earnings (P/E) ratio of -2.37.
On 2025-11-25, Relmada Therapeutics(RLMD) stock traded between a low of $3.99 and a high of $4.44. Shares are currently priced at $4.18, which is +4.8% above the low and -5.9% below the high.
Relmada Therapeutics(RLMD) shares are trading with a volume of 787.52K, against a daily average of 1.35M.
In the last year, Relmada Therapeutics(RLMD) shares hit a 52-week high of $5.12 and a 52-week low of $0.24.
In the last year, Relmada Therapeutics(RLMD) shares hit a 52-week high of $5.12 and a 52-week low of $0.24.
RLMD News
Relmada Therapeutics (RLMD) is a clinical-stage pharma company with no commercialized products and a $141 million market cap. RLMD has shown strong technical m...